Pular para o conteúdo principal
Ranking Invest

TNDM - Tandem Diabetes Care, Inc.

Segmento: HealthcareTandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Análise Ranking Invest

Valuation estimado
-15,53%
-$ 493.07 Mi
Valor de Mercado
$ 1.19 Bi
Desconto (AV)-341.4%
IVR
-0.41A companhia vale -0,41 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.48O valuation alternativo equivale a -48% do valor de mercado da companhia.
MLL
-0.48O lucro líquido dos controladores em 16 trimestres equivale a -48% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 130.39 Mi

Dívida Líquida

$ 539.76 Mi

L4T

-$ 63.31 Mi

MM4T

-6.31%

Indicadores Básicos

ROE

-48.56%

Índices de Previsibilidade

Receita Líquida

D0.12

Lucro

D0.62

Margem

D0.64

Índices de Tendência

Receita Líquida

C6.72

Lucro

C3.03

Margem

C4.11

Índices de Endividamento

DIV/PAT

4.14

DIV/L4T

-8.52

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.